Prot #THE630-21-101: A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

Project: Research project

Project Details

StatusActive
Effective start/end date12/19/23 → 12/19/24

Funding

  • Worldwide Clinical Trials, Inc. (Prot #THE630-21-101 // Prot #THE630-21-101)
  • Theseus Pharmaceuticals, Inc. (Prot #THE630-21-101 // Prot #THE630-21-101)